Concepedia

Pamela Grenci

PG

Statistics

Publications

3

Citations

228

H-Index

3

Active since

2009

Affiliations

National Cancer Institute(Current)

Princess Margaret Cancer Centre

Sunnybrook Health Science Centre

Pamela Grenci is an author at National Cancer Institute specializing in medicine, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

2009–2010

3

Publications

3

Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours

Helen Mackay, Hal W. Hirte, Terrence J. Colgan et al. · European Journal of Cancer · 2010 · 145 citations

, , +7

A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium

Sara Taylor, Stephen Chia, Susan Dent et al. · The Oncologist · 2010 · 67 citations · Full text

A phase II study of GW786034 (pazopanib) in patients with recurrent or metastatic invasive breast carcinoma: Results after completion of stage I: A trial of the Princess Margaret Hospital Phase II Consortium

Sara Taylor, S. Chia, Susan Dent et al. · Journal of Clinical Oncology · 2009 · 16 citations

, , +15

Rows per page

1–3 of 3